Blog

The tale of a person who ended up in the hospital experiencing hallucinations illustrates the dangers of depending on unverified online resources for medical advice. This individual sought a low-sodium meal plan from an artificial intelligence chatbot, ChatGPT, and subsequently faced serious health issues that specialists associate with the bot's unverified guidance. This incident serves as a stark and sobering reminder that while AI can be a powerful tool, it lacks the foundational knowledge, context, and ethical safeguards necessary for providing health and wellness information. Its output is a reflection of the data it has been trained on, not a…

Numerosos estudios emergentes están proponiendo que las personas pueden manifestar síntomas leves de esclerosis múltiple (EM) mucho antes de obtener un diagnóstico formal. Estos signos tempranos, que suelen pasar desapercibidos, son ahora un foco clave para investigadores que buscan optimizar el tiempo de detección y tratamiento. Al identificar estos indicadores preclínicos, los profesionales de la medicina esperan intervenir antes, lo que podría desacelerar el avance de la enfermedad y mejorar los resultados a largo plazo para los pacientes. Este cambio de enfoque, de manejar la enfermedad tras su aparición a comprender sus fases iniciales, representa un avance significativo en la…

A growing trend in the use of GLP-1 receptor agonists for weight loss involves a practice known as "microdosing." This experimental approach, which entails taking a lower-than-prescribed dose of these popular medications, is being adopted by some patients in an attempt to manage side effects, reduce costs, or achieve more gradual weight loss. However, this strategy is not without significant debate, and medical professionals are carefully weighing the potential benefits against a number of substantial risks.The appeal of microdosing is primarily driven by a desire to mitigate the common, and often severe, gastrointestinal side effects associated with the standard therapeutic…